Navigation Links
GeoVax Labs, Inc. Announces First Quarter Financial Results
Date:4/27/2011

which achieved an impressive 70% protection against simian immunodeficiency virus (SIV) infection in nonhuman primates.  GM-CSF (granulocyte–macrophage colony stimulating factor) is a cytokine (growth-stimulating protein) that serves to expand and mature cells that initiate immune responses.  We are very pleased that HVTN will also be conducting this Phase 1 clinical trial, which we expect to begin later this year.  In addition, we have commenced planning for a Phase 2b clinical trial of our preventative vaccine—vaccine production is being scheduled and discussions are underway with government sponsors for protocol development."

Summarized financial information is attached.  Further information concerning the Company's financial position and results of operations are included in its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission.

About GeoVaxGeoVax Labs, Inc. is a biotechnology company developing human vaccines for diseases caused by HIV (Human Immunodeficiency Virus – that leads to AIDS). Our HIV/AIDS vaccine technology is exclusively licensed from Emory University in Atlanta, GA, and is the subject of more than 20 issued or filed patent applications.  GeoVax's vaccines are unique in expressing virus-like particles that display the trimeric membrane bound form of the HIV-1 envelope glycoprotein.  Our preventative vaccines are designed for use in uninfected people to prevent acquisition of HIV-1 and are moving forward in human clinical trials conducted by the HIV Vaccine Trials Network (HVTN). The HVTN, funded through a cooperative agreement with the NIH, is the largest worldwide clinical trials program dedicated to the development and testing of AIDS vaccines.  GeoVax's vaccines also may be effective as a therapeutic treatment (for people already infected with the HIV-1 virus); a Phase 1/2 human trial for the therapeutic application of our vaccine is ongoing. 
'/>"/>

SOURCE GeoVax Labs, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. GeoVax Labs Reports Fourth Quarter and Year-End 2010 Financial Results
2. GeoVax Labs CSO Dr. Harriet L. Robinson to be Honored at 2011 Georgia Bio (GaBio) Community Awards Ceremony
3. GeoVax Labs Inc. Announces Results of 2010 Annual Stockholders Meeting
4. GeoVax Labs, Inc. Reports Data on Prototype Adjuvant - Supplemented HIV Vaccine Tested in Preclinical Animal Studies
5. GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress
6. GeoVax Labs, Inc. Moving Operations to Smyrna, Georgia
7. Formatech, Inc. to Donate Services to Formulate and Fill GeoVax Labs, Inc. HIV/AIDS Vaccine Under Its Fillanthropy(TM) Program
8. Encouraging HIV/AIDS Vaccine Trial Results Support GeoVax Labs, Inc. Strategy
9. GeoVax Labs Requests pre-IND Meeting With FDA
10. GeoVax to Present at the Rodman & Renshaw 11th Annual Healthcare Conference
11. GeoVax Labs, Inc. Provides Clinical Studies Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... 31, 2015 Materials in Society ...   June 30 2015   Elsevier , ... and services and publishing home of Materials Today , ... the Materials in Society  Lecture Series . ... 8 th International Conference on Materials for Advanced Technologies ...
(Date:3/31/2015)... March 31, 2015   Mapi expands ... Medical Affairs and global Risk Management strength with ... previously announced acquisition . ... by a global team that includes physicians, pharmacists, ... of experience in navigating complex safety requirements throughout ...
(Date:3/31/2015)... Angeles, CA (PRWEB) March 31, 2015 ... and Professors from the top U.S and International Medical ... share their latest research on the application of stem ... diseases. The symposium is organized and funded by the ... independent nonprofit that has been convening intimate meetings of ...
(Date:3/30/2015)... San Francisco, CA (PRWEB) March 30, 2015 ... and tax incentives provided you the government, major companies ... state and local governments setting future mandates for renewable ... power as an option. , Solara Power is a ... to several incentive programs available that allow qualifying homeowners ...
Breaking Biology Technology:Elsevier Materials Science Council Introduces the Materials in Society Lecture Series at the International Conference on Materials for Advanced Technologies (ICMAT) 2Elsevier Materials Science Council Introduces the Materials in Society Lecture Series at the International Conference on Materials for Advanced Technologies (ICMAT) 3Mapi expands Pharmacovigilance and Risk Management capabilities 2Mapi expands Pharmacovigilance and Risk Management capabilities 3Sight Restoration Through Stem Cell Therapy - Subject of June Symposium of Experts 2Solara Power Announces Residential Solar Power with No Up-Front Fees 2
... Innocoll, Inc., a,privately held specialty pharmaceutical company, ... investment to raise $30 million through the ... placement with three,institutional investors led by Camulos ... and Morgan Stanley & Co, Incorporated. The ...
... is a new drug being,studied to prevent fractures in ... 3 clinical trial using denosumab were presented,Friday evening at ... from the Seattle Cancer Care Alliance., Denosumab is ... -- specialized cells that break down bone. Because it ...
... Per Acre Yield Advantage in Key ... Maturity Zone, ... showed that farmers who used DEKALB(R) corn seed stacked,with YieldGard VT Triple(TM) ... seed corn brands and,technologies in 2007., Data from nearly 1,700 on-farm ...
Cached Biology Technology:Innocoll Announces Closing of $30 Million Equity Financing Investment 2Innocoll Announces Closing of $30 Million Equity Financing Investment 3Innocoll Announces Closing of $30 Million Equity Financing Investment 4Innocoll Announces Closing of $30 Million Equity Financing Investment 5New Drug to Prevent Bone Loss Caused by Breast Cancer Treatment 2Farmers Across the U.S. Realize Double-Digit Yield Advantage From DEKALB(R) Corn Seeds With Triple-Stacked Traits 2
(Date:3/31/2015)... , March 31, 2015   Guidepoint , ... launch of the Post-Surgical Pain Management TRACKER, part of ... tracking usage trends in the medical device and therapeutics ... to data including treatment volumes, market share, and adoption ... pain associated with joint surgery. The Post-Surgical ...
(Date:3/24/2015)... Markets ( http://www.researchandmarkets.com/research/kvdtcw/face_and_voice ) has announced the addition of ... report to their offering. This report analyzes the ... the following Segments: Face Biometrics, and Voice Biometrics. The report provides ... Japan , Europe , ... Africa , and Latin America ...
(Date:3/23/2015)... --  HOYOS Labs , a leading global authentication infrastructure ... Company will demonstrate multiple biometrics-based technologies under its identity ... on March 23 through 25, 2015, in ... IEEE Biometric Open Protocol Standard; free biometrics-based consumer app, ... system. BOPS was invented by HOYOS Labs and contributed ...
Breaking Biology News(10 mins):Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 2Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 3Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 4Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 5Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 6HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 3
... New Rochelle, NY, October 3, 2008Novel platform technologies and ... of molecular diagnostics, reports Genetic Engineering and Biotechnology ... products can be significant as Kalorama Information predicts that ... reach $5.4 billion in four years, according to an ...
... Case Western Reserve University School of Medicine has been ... Children,s Study, the National Institutes of Health,s comprehensive study on ... At a briefing today, NIH officials named ... 36 new and existing study centers which would recruit study ...
... R.I. [Brown University] Brown University, with lead partner ... awarded a $12-million, five-year contract to expand its participation ... aimed at improving child health. The National Institute ... the 27 Institutes and Centers at the National Institutes ...
Cached Biology News:Genetic Engineering & Biotechnology News reports on growing role of molecular diagnostics 2NIH selects Case Western Reserve University to participate in National Children's Study 2Brown University and Women & Infants Hospital expand national children's study to Bristol County 2Brown University and Women & Infants Hospital expand national children's study to Bristol County 3Brown University and Women & Infants Hospital expand national children's study to Bristol County 4
... is causing shortages in your laboratory or fellow ... unwanted distractions, problems and delays. • ... and endeavour! Bring us your idea and let ... We work under ISO 9001 quality assurance in ...
Topoisomerase I...
...
... ADAM17 Activity Kit TNF-α Converting Enzyme Activity ... LIGHT. AVOID FREEZE/THAW CYCLES. The InnoZyme™ TACE ... assay designed to measure human TACE activity ... for screening enzyme inhibitors. An Anti-Human TACE-Coated ...
Biology Products: